MENU
+Compare
JNJ
Stock ticker: NYSE
AS OF
Nov 24, 04:59 PM (EDT)
Price
$205.92
Change
+$2.02 (+0.99%)
Capitalization
491.26B

JNJ Johnson & Johnson Forecast, Technical & Fundamental Analysis

Johnson & Johnson is the world's largest and most diverse healthcare firm... Show more

JNJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for JNJ with price predictions
Nov 21, 2025

JNJ's RSI Oscillator is staying in overbought zone for 6 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

JNJ broke above its upper Bollinger Band on November 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on JNJ as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for JNJ just turned positive on November 12, 2025. Looking at past instances where JNJ's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JNJ advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 260 cases where JNJ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. JNJ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.196) is normal, around the industry mean (8.944). P/E Ratio (19.700) is within average values for comparable stocks, (24.214). Projected Growth (PEG Ratio) (1.102) is also within normal values, averaging (2.072). Dividend Yield (0.025) settles around the average of (0.026) among similar stocks. P/S Ratio (5.368) is also within normal values, averaging (3.672).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
JNJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

JNJ is expected to report earnings to fall 9.64% to $2.53 per share on January 21

Johnson & Johnson JNJ Stock Earnings Reports
Q4'25
Est.
$2.53
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.19
Q4'24
Beat
by $0.02
The last earnings report on October 14 showed earnings per share of $2.80, beating the estimate of $2.76. With 2.76M shares outstanding, the current market capitalization sits at 491.26B.
A.I.Advisor
published Dividends

JNJ is expected to pay dividends on December 09, 2025

Johnson & Johnson JNJ Stock Dividends
A dividend of $1.30 per share will be paid with a record date of December 09, 2025, and an ex-dividend date of November 25, 2025. The last dividend of $1.30 was paid on September 09. Read more...
A.I. Advisor
published General Information

General Information

an investment holding company with interests in health care products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
One Johnson and Johnson Plaza
Phone
+1 732 524-0400
Employees
131900
Web
https://www.jnj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QDTE33.770.39
+1.17%
Roundhill Innovt-100 0DTE CovCllStratETF
DIVZ35.810.33
+0.93%
Opal Dividend Income ETF
QQWZ24.280.17
+0.68%
Pacer Cash COWZ 100-Nasdaq100RotatorETF
IEMG65.58-0.06
-0.09%
iShares Core MSCI Emerging Markets ETF
FCO2.91-0.03
-1.02%
abrdn Global Income Fund

JNJ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.41%
PFE - JNJ
59%
Loosely correlated
+2.62%
NVS - JNJ
56%
Loosely correlated
+2.37%
GSK - JNJ
50%
Loosely correlated
+2.34%
BMY - JNJ
46%
Loosely correlated
+0.67%
ABBV - JNJ
45%
Loosely correlated
+2.98%
More